Based on the above, inhibiting or reducing IL-6 expression and the IL-6-mediated JAK2-STAT1/3 signaling pathway in AGA can alleviate the severity of MSU crystal-induced arthritis and inflammation. This evidence concerns the gene IL6 and arthritic joint disease.